HEADER TRANSFERASE/TRANSFERASE INHIBITOR 04-NOV-16 5TTS TITLE JAK3 WITH COVALENT INHIBITOR 4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE JAK3; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN (UNP RESIDUES 812-1124); COMPND 5 SYNONYM: JANUS KINASE 3,JAK-3,LEUKOCYTE JANUS KINASE,L-JAK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: JAK3; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF21; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS KINASE, COVALENT, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR F.F.VAJDOS REVDAT 3 30-OCT-24 5TTS 1 REMARK REVDAT 2 22-MAR-17 5TTS 1 JRNL REVDAT 1 22-FEB-17 5TTS 0 JRNL AUTH A.THORARENSEN,M.E.DOWTY,M.E.BANKER,B.JUBA,J.JUSSIF,T.LIN, JRNL AUTH 2 F.VINCENT,R.M.CZERWINSKI,A.CASIMIRO-GARCIA,R.UNWALLA, JRNL AUTH 3 J.I.TRUJILLO,S.LIANG,P.BALBO,Y.CHE,A.M.GILBERT,M.F.BROWN, JRNL AUTH 4 M.HAYWARD,J.MONTGOMERY,L.LEUNG,X.YANG,S.SOUCY,M.HEGEN,J.COE, JRNL AUTH 5 J.LANGILLE,F.VAJDOS,J.CHRENCIK,J.B.TELLIEZ JRNL TITL DESIGN OF A JANUS KINASE 3 (JAK3) SPECIFIC INHIBITOR JRNL TITL 2 1-((2S,5R)-5-((7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO) JRNL TITL 3 -2-METHYLPIPERIDIN-1-YL)PROP-2-EN-1-ONE (PF-06651600) JRNL TITL 4 ALLOWING FOR THE INTERROGATION OF JAK3 SIGNALING IN HUMANS. JRNL REF J. MED. CHEM. V. 60 1971 2017 JRNL REFN ISSN 1520-4804 JRNL PMID 28139931 JRNL DOI 10.1021/ACS.JMEDCHEM.6B01694 REMARK 2 REMARK 2 RESOLUTION. 2.34 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.6 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 23.44 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.0 REMARK 3 NUMBER OF REFLECTIONS : 13995 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.205 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.263 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 711 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 7 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.34 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.53 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.41 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2790 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2383 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2638 REMARK 3 BIN R VALUE (WORKING SET) : 0.2365 REMARK 3 BIN FREE R VALUE : 0.2658 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.45 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 152 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2162 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 20 REMARK 3 SOLVENT ATOMS : 184 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.24 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 47.46 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.78790 REMARK 3 B22 (A**2) : -1.90970 REMARK 3 B33 (A**2) : 0.12180 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.293 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.402 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.262 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.342 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.253 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2235 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3022 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 772 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 47 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 338 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2235 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 271 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2650 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.06 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.06 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.48 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5TTS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 07-NOV-16. REMARK 100 THE DEPOSITION ID IS D_1000224820. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-APR-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ DW REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14122 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.340 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.05000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.3 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : 0.39100 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2M (NH4)2SO4, 2% REMARK 280 PHENYLUREA, PH 8.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.68450 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 44.77500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.87700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 44.77500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.68450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.87700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 804 REMARK 465 GLY A 805 REMARK 465 HIS A 806 REMARK 465 HIS A 807 REMARK 465 HIS A 808 REMARK 465 HIS A 809 REMARK 465 HIS A 810 REMARK 465 HIS A 811 REMARK 465 GLN A 812 REMARK 465 ASP A 813 REMARK 465 HIS A 859 REMARK 465 SER A 860 REMARK 465 GLY A 892 REMARK 465 PRO A 893 REMARK 465 GLY A 894 REMARK 465 ARG A 895 REMARK 465 GLN A 896 REMARK 465 SER A 897 REMARK 465 GLY A 1039 REMARK 465 CYS A 1040 REMARK 465 GLU A 1041 REMARK 465 ARG A 1042 REMARK 465 ASP A 1043 REMARK 465 GLY A 1101 REMARK 465 SER A 1102 REMARK 465 ARG A 1103 REMARK 465 GLY A 1104 REMARK 465 CYS A 1105 REMARK 465 GLU A 1106 REMARK 465 THR A 1107 REMARK 465 HIS A 1108 REMARK 465 ALA A 1109 REMARK 465 PHE A 1110 REMARK 465 THR A 1111 REMARK 465 ALA A 1112 REMARK 465 HIS A 1113 REMARK 465 PRO A 1114 REMARK 465 GLU A 1115 REMARK 465 GLY A 1116 REMARK 465 LYS A 1117 REMARK 465 HIS A 1118 REMARK 465 HIS A 1119 REMARK 465 SER A 1120 REMARK 465 LEU A 1121 REMARK 465 SER A 1122 REMARK 465 PHE A 1123 REMARK 465 SER A 1124 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ILE A 816 CD1 REMARK 470 ASN A 832 CG OD1 ND2 REMARK 470 PHE A 833 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 866 NE CZ NH1 NH2 REMARK 470 ARG A 870 CZ NH1 NH2 REMARK 470 TYR A 981 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ARG A 984 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 985 CG CD OE1 OE2 REMARK 470 LYS A1026 CD CE NZ REMARK 470 GLU A1055 OE1 OE2 REMARK 470 GLU A1069 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 832 122.31 -29.01 REMARK 500 ASP A 842 71.97 -118.60 REMARK 500 ARG A 948 -11.39 72.69 REMARK 500 ALA A 966 -169.11 -129.00 REMARK 500 ASP A 967 82.34 47.63 REMARK 500 TRP A1099 141.02 95.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A4280 DISTANCE = 5.86 ANGSTROMS REMARK 525 HOH A4281 DISTANCE = 6.99 ANGSTROMS REMARK 525 HOH A4282 DISTANCE = 7.32 ANGSTROMS REMARK 525 HOH A4283 DISTANCE = 7.73 ANGSTROMS REMARK 525 HOH A4284 DISTANCE = 8.93 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 7KU A 4000 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5TTU RELATED DB: PDB REMARK 900 RELATED ID: 5TTV RELATED DB: PDB DBREF 5TTS A 812 1124 UNP P52333 JAK3_HUMAN 812 1124 SEQADV 5TTS MET A 804 UNP P52333 INITIATING METHIONINE SEQADV 5TTS GLY A 805 UNP P52333 EXPRESSION TAG SEQADV 5TTS HIS A 806 UNP P52333 EXPRESSION TAG SEQADV 5TTS HIS A 807 UNP P52333 EXPRESSION TAG SEQADV 5TTS HIS A 808 UNP P52333 EXPRESSION TAG SEQADV 5TTS HIS A 809 UNP P52333 EXPRESSION TAG SEQADV 5TTS HIS A 810 UNP P52333 EXPRESSION TAG SEQADV 5TTS HIS A 811 UNP P52333 EXPRESSION TAG SEQADV 5TTS SER A 1048 UNP P52333 CYS 1048 ENGINEERED MUTATION SEQRES 1 A 321 MET GLY HIS HIS HIS HIS HIS HIS GLN ASP PRO THR ILE SEQRES 2 A 321 PHE GLU GLU ARG HIS LEU LYS TYR ILE SER GLN LEU GLY SEQRES 3 A 321 LYS GLY ASN PHE GLY SER VAL GLU LEU CYS ARG TYR ASP SEQRES 4 A 321 PRO LEU GLY ASP ASN THR GLY ALA LEU VAL ALA VAL LYS SEQRES 5 A 321 GLN LEU GLN HIS SER GLY PRO ASP GLN GLN ARG ASP PHE SEQRES 6 A 321 GLN ARG GLU ILE GLN ILE LEU LYS ALA LEU HIS SER ASP SEQRES 7 A 321 PHE ILE VAL LYS TYR ARG GLY VAL SER TYR GLY PRO GLY SEQRES 8 A 321 ARG GLN SER LEU ARG LEU VAL MET GLU TYR LEU PRO SER SEQRES 9 A 321 GLY CYS LEU ARG ASP PHE LEU GLN ARG HIS ARG ALA ARG SEQRES 10 A 321 LEU ASP ALA SER ARG LEU LEU LEU TYR SER SER GLN ILE SEQRES 11 A 321 CYS LYS GLY MET GLU TYR LEU GLY SER ARG ARG CYS VAL SEQRES 12 A 321 HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL GLU SER SEQRES 13 A 321 GLU ALA HIS VAL LYS ILE ALA ASP PHE GLY LEU ALA LYS SEQRES 14 A 321 LEU LEU PRO LEU ASP LYS ASP TYR TYR VAL VAL ARG GLU SEQRES 15 A 321 PRO GLY GLN SER PRO ILE PHE TRP TYR ALA PRO GLU SER SEQRES 16 A 321 LEU SER ASP ASN ILE PHE SER ARG GLN SER ASP VAL TRP SEQRES 17 A 321 SER PHE GLY VAL VAL LEU TYR GLU LEU PHE THR TYR CYS SEQRES 18 A 321 ASP LYS SER CYS SER PRO SER ALA GLU PHE LEU ARG MET SEQRES 19 A 321 MET GLY CYS GLU ARG ASP VAL PRO ALA LEU SER ARG LEU SEQRES 20 A 321 LEU GLU LEU LEU GLU GLU GLY GLN ARG LEU PRO ALA PRO SEQRES 21 A 321 PRO ALA CYS PRO ALA GLU VAL HIS GLU LEU MET LYS LEU SEQRES 22 A 321 CYS TRP ALA PRO SER PRO GLN ASP ARG PRO SER PHE SER SEQRES 23 A 321 ALA LEU GLY PRO GLN LEU ASP MET LEU TRP SER GLY SER SEQRES 24 A 321 ARG GLY CYS GLU THR HIS ALA PHE THR ALA HIS PRO GLU SEQRES 25 A 321 GLY LYS HIS HIS SER LEU SER PHE SER HET 7KU A4000 20 HETNAM 7KU 1-{(3R)-3-[(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL) HETNAM 2 7KU AMINO]PIPERIDIN-1-YL}PROPAN-1-ONE FORMUL 2 7KU C14 H19 N5 O FORMUL 3 HOH *184(H2 O) HELIX 1 AA1 GLU A 818 ARG A 820 5 3 HELIX 2 AA2 PRO A 862 ALA A 877 1 16 HELIX 3 AA3 CYS A 909 HIS A 917 1 9 HELIX 4 AA4 ASP A 922 ARG A 943 1 22 HELIX 5 AA5 ALA A 951 ARG A 953 5 3 HELIX 6 AA6 PRO A 990 TYR A 994 5 5 HELIX 7 AA7 ALA A 995 ASN A 1002 1 8 HELIX 8 AA8 ARG A 1006 THR A 1022 1 17 HELIX 9 AA9 ASP A 1025 CYS A 1028 5 4 HELIX 10 AB1 SER A 1029 MET A 1038 1 10 HELIX 11 AB2 PRO A 1045 GLU A 1056 1 12 HELIX 12 AB3 PRO A 1067 TRP A 1078 1 12 HELIX 13 AB4 SER A 1081 ARG A 1085 5 5 HELIX 14 AB5 SER A 1087 LEU A 1098 1 12 SHEET 1 AA1 5 LEU A 822 GLY A 831 0 SHEET 2 AA1 5 GLY A 834 TYR A 841 -1 O ARG A 840 N LYS A 823 SHEET 3 AA1 5 ALA A 850 LEU A 857 -1 O ALA A 850 N TYR A 841 SHEET 4 AA1 5 ARG A 899 GLU A 903 -1 O MET A 902 N ALA A 853 SHEET 5 AA1 5 TYR A 886 SER A 890 -1 N GLY A 888 O VAL A 901 SHEET 1 AA2 2 CYS A 945 VAL A 946 0 SHEET 2 AA2 2 LYS A 972 LEU A 973 -1 O LYS A 972 N VAL A 946 SHEET 1 AA3 2 ILE A 955 SER A 959 0 SHEET 2 AA3 2 HIS A 962 ILE A 965 -1 O LYS A 964 N LEU A 956 SHEET 1 AA4 2 TYR A 980 VAL A 982 0 SHEET 2 AA4 2 ILE A1003 SER A1005 -1 O PHE A1004 N TYR A 981 LINK SG CYS A 909 C1 7KU A4000 1555 1555 1.81 CISPEP 1 ASN A 832 PHE A 833 0 1.92 SITE 1 AC1 11 LEU A 828 GLY A 829 ALA A 853 GLU A 903 SITE 2 AC1 11 LEU A 905 GLY A 908 CYS A 909 ARG A 911 SITE 3 AC1 11 ASP A 912 LEU A 956 HOH A4122 CRYST1 47.369 75.754 89.550 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021111 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013201 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011167 0.00000